Bio-Thera And Pharmapark Add Cosentyx Rival To Russia-CIS Collaboration

Secukinumab Biosimilar Expands Deal That Already Includes Golimumab And Ustekinumab

 
• By David Wallace
  
Map Of Russia & The Commonwealth Of Independent States
Bio-Thera and Pharmapark have expanded their collaboration in Russia and the CIS • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business